PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsSupraventricular tachycardia
MeSH D013617 - supraventricular tachycardia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D013610:Tachycardia
0 Companies
0 Drugs
Success rate
D013617: 
Supraventricular tachycardia
D013612:Ectopic atrial tachycardia
0 Companies
0 Drugs
Success rate
D013613:Ectopic junctional tachycardia
0 Companies
0 Drugs
Success rate
D013616:Sinus tachycardia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MPhenylephrine, Isoproterenol Duo-medihaler  1982-01-01   
AbbVieVerapamil, Trandolapril Tarka  1996-10-22   
Accord HealthcareDiltiazem Diltiazem  2020-04-28   
Acella PharmaceuticalsAmiodarone Amiodarone  2008-10-30   
Adare PharmaceuticalsPropranolol Propranolol  2011-07-15   
Alembic PharmaceuticalsDiltiazem Diltiazem  2024-10-18   
AllerganDiltiazem Dilacor  1992-05-29   
Diltiazem Cartia  1998-07-09   
Diltiazem Diltiazem  1997-10-10   
Procainamide Procainamide  1982-01-01   
Propafenone Propafenone  2000-10-24   
Propranolol Propranolol  1985-07-30   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1986-04-18   
Sotalol Sotalol  2000-07-13   
Diltiazem Taztia  2003-04-10   
Verapamil Verapamil  1986-09-24   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/1
Phase 3
100%
20/20
Approved: 16Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use